AzTrials
AzTrials

MyopiaNCT01839318

Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses

A study testing Nelfilcon A contact lenses, Omafilcon A contact lenses and Etafilcon A contact lenses in people with Myopia and Hyperopia, run by Alcon Research.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study was to compare three CE-marked daily disposable contact lenses for tear film stability as measured by pre-lens non-invasive keratograph break up time (PL NIK-BUT). Secondarily, contact lens surface wettability was assessed. Read more about this study

Who is it for?
Ages 18 to 44 years
Conditions the study is for
Myopia, Hyperopia, Refractive Error
What is being tested?
Nelfilcon A contact lenses, Omafilcon A contact lenses and Etafilcon A contact lenses
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
No sites listed yet
Study dates
Apr 2013to Jun 2013
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 44 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Sign Informed Consent.
  • Adapted soft contact lens wearer.
  • Willing to wear contact lenses up to 12 hours and attend all study visits.
  • Vision correctable to 0.1 (logMAR) or better in each eye at distance with pre-study lenses at Visit 1.
  • Contact lens prescription within the power range specified in the protocol.
  • Other protocol-defined inclusion criteria may apply.

Who cannot join

  • Any ocular infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear.
  • Any use of systemic or ocular medications that would contraindicate contact lens wear.
  • Any ocular finding observed during the Visit 1 examination that would contraindicate contact lens wear.
  • Monocular (only 1 eye with functional vision) or fit with only 1 lens.
  • History of herpetic keratitis, ocular surgery, or irregular cornea.
  • Known pregnancy.
Show all 9Show fewer
  • Unstable tear film with a NIK-BUT value below 13 seconds in either eye without lenses.
  • Participation in any clinical study within 30 days of Visit 1.
  • Other protocol-defined exclusion criteria may apply.

About this study

Official title: Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses Using Ring Mire Projection

The purpose of this study was to compare three CE-marked daily disposable contact lenses for tear film stability as measured by pre-lens non-invasive keratograph break up time (PL NIK-BUT). Secondarily, contact lens surface wettability was assessed.

Read the detailed description

Each participant wore 3 brands of contact lenses in a randomized, cross-over fashion, with a washout phase of at least 1 night between brands.

Being tested
Nelfilcon A contact lenses, Omafilcon A contact lenses, Etafilcon A contact lenses
Keywords
Soft contact lenses, Daily disposable contact lenses, Tear Film Break Up Time, Contact lens wettability
Medical subject headings
Myopia, Hyperopia, Refractive Errors

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nelfilcon A contact lensesDevice

    Also called DAILIES® AquaComfort Plus®

  • Omafilcon A contact lensesDevice

    Also called Proclear® 1 day

  • Etafilcon A contact lensesDevice

    Also called 1-DAY ACUVUE® MOIST®

Study groups in NCT01839318
Study groupRoleWhat they receive
DAILIES AquaComfort PlusExperimentalNelfilcon A contact lenses worn first, followed by etafilcon A and omafilcon A in randomized order. Each product worn for 1 day, 12 hours.
Receives: Device: Nelfilcon A contact lenses
1-DAY ACUVUE MOISTActive comparatorEtafilcon A contact lenses worn first, followed by nelfilcon A and omafilcon A in randomized order. Each product worn for 1 day, 12 hours.
Receives: Device: Etafilcon A contact lenses
Proclear 1 dayActive comparatorOmafilcon A contact lenses worn first, followed by etafilcon A and nelfilcon A in randomized order. Each product worn for 1 day, 12 hours.
Receives: Device: Omafilcon A contact lenses

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pre-Lens Non-Invasive Keratograph Break Up Time (PL NIK-BUT) at 8 Hours

    The pre-lens tear film is the layer of tears located on top of the contact lens (i.e., between the eye lid and the contact lens). The time required for a dry spot to appear on the corneal surface after blinking is referred to as the tear film break-up time. Circular images were projected onto the contact lens using an Oculus Keratograph 5 and the tear film reflection was observed. PL NIK-BUT was recorded at the first sign of distortion. A longer tear film break-up time indicates a more stable tear film. One eye (right eye) contributed to the mean.

    Measured: Hour 8

Secondary outcomes (1)
  1. Total Wettability Score

    The investigator graded lens wettability by corneal region using a scale from 0 (fully wettable) to 3 (clearly visible ring distortions in more than 1/3 of ring reflection zone). The total wettability score per eye was calculated by averaging the grade of each of the 5 corneal regions (central, superior, nasal, inferior, and temporal). One eye (right eye) contributed to the mean.

    Measured: Hour 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2013 (estimated)
  2. Study startApr 2013
  3. Primary completionJun 2013
  4. Study completionJun 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01839318
Sponsor's protocol ID
A01336
Status last verified
May 2014
First submitted
22 Apr 2013
Last updated
20 Jun 2014
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Nelfilcon A contact lenses, Omafilcon A contact lenses and Etafilcon A contact lenses in people with Myopia and Hyperopia, run by Alcon Research.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jun 2014. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 20 Jun 2014). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pre-Lens Non-Invasive Keratograph Break Up Time (PL NIK-BUT) at 8 Hours (time frame: Hour 8). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jun 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in